Saturday 17 October 2026
Export ITOC’s income statement to Excel — free account
iTonic Holdings Ltd.
ITOC Healthcare Medical Devices
iTonic Holdings Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $523,000.00, up 16.7% from fiscal 2024.
3.84
0.17
−4.24%
Follow ITOC
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Piotroski F-Score |
2 | 4 | — | — |
Altman Z-Score |
64.62 | 1,000.59 | — | — |
Altman Z″-Score (non-manufacturers) |
5.57 | 17.02 | (3.48) | 1.88 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(3.73) | (1.95) | (3.76) | — |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.66 | 0.00 | 0.00 | 0.00 |
EV/FCF |
0.66 | 0.00 | 0.00 | 0.00 |
Quick Ratio |
6.98 | 12.05 | 0.36 | 0.76 |
Current Ratio |
8.83 | 12.40 | 0.44 | 1.06 |
Net Debt/EBITDA |
0.54 | 7.80 | 0.76 | (2.63) |
Debt/Assets |
1.57% | 3.69% | 0.00% | 0.00% |
Debt/Equity |
0.02 | 0.04 | 0.00 | 0.00 |
Asset Turnover |
0.07 | 0.11 | 0.42 | 0.00 |
Operating CF/Net income |
0.63 | 1.17 | 0.26 | (1.38) |
Capex/Depreciation |
(0.29) | (0.07) | 0.00 | — |
| (71.24%) | (20.35%) | (55.92%) | 0.00% | |
| (64.45%) | (15.84%) | (15.98%) | 0.00% | |
ROIC |
(60.67%) | (176.42%) | (243.26%) | 3.55% |
Return on Tangible Assets |
(139.16%) | (10.68%) | 39.28% | 218.75% |
Average Days of Receivables |
212.65 | 270.04 | 119.79 | 240.60 |
Research and Development Expense of Revenue |
87.78% | 20.82% | 13.44% | 10.84% |
Selling, General and Administrative Expense of Revenue |
966.58% | 236.08% | 110.24% | 67.21% |
Intangible Assets out of Total Assets |
0.48 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
563.19% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.03 | 0.04 | 0.05 | 0.06 |
Operating CF per Share |
(0.20) | (0.06) | (0.01) | (0.01) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.20) | (0.06) | (0.01) | (0.01) |
Cash per Share |
0.18 | 0.48 | 0.02 | 0.01 |
Shareholders Equity per Share |
0.51 | 0.49 | 0.03 | 0.05 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.51 | 0.49 | 0.03 | 0.05 |
Free Cash Flow |
(3.24) | (0.78) | (0.06) | (0.12) |
Working Capital |
3.63 | 6.14 | (0.67) | 0.04 |
Capital Expenditures |
0.00 | 0.00 | — | — |
Net Current Asset Value |
3.12 | 6.14 | (0.78) | (0.13) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
0.35 | 0.28 | 0.09 | — |
Cash ROIC |
(28.90%) | (6.16%) | (11.91%) | (18.49%) |
Accounts Receivable Turnover |
1.64 | 1.67 | 1.92 | 0.00 |
Accounts Payable Turnover |
5.06 | 4.72 | 10.81 | 0.00 |
Inventory Turnover |
2.30 | 0.79 | 1.54 | 0.00 |
Average Days of Payables |
124.78 | 56.66 | 41.64 | 33.62 |
Days of Inventory on Hand |
97.92 | 639.57 | 120.97 | 458.65 |
Average Receivables |
0.32 | 0.27 | 0.33 | — |
Average Payables |
0.04 | 0.01 | 0.01 | — |
Average Inventory |
0.08 | 0.08 | 0.10 | — |
Average Assets |
7.91 | 4.17 | 1.51 | — |
Average Common Equity |
7.16 | 3.25 | 0.43 | — |
Columns are period end dates · fundamentals updated 2 Oct 2026